Immunogenicity of COVID-19 vaccines in patients with cirrhosis: A meta-analysis
The immunogenicity of COVID-19 vaccines in patients with liver cirrhosis remains largely unknown. The purpose of this meta-analysis was to investigate the immunogenicity of COVID-19 vaccines in patients with cirrhosis and compare the humoral and cellular immune responses following complete COVID-19...
Saved in:
| Main Authors: | Lichen Ouyang, Gang Lei, Yeli Gong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2326316 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the Immunogenicity of an Intranasal Microparticle Combination Vaccine for COVID-19 and Influenza
by: Sharon Vijayanand, et al.
Published: (2025-03-01) -
Diminishing reactogenicity with preserved immunogenicity in COVID-19 vaccines: A longitudinal observation from primary to updated booster vaccine cohorts
by: Hyun Myung Kang, et al.
Published: (2025-07-01) -
COVID-19 in decompensated cirrhosis
by: O. V. Tashchyan, et al.
Published: (2021-01-01) -
Prospective study of safety, immunogenicity, and efficacy of inactivated COVID-19 vaccine in tuberous sclerosis complex children on sirolimus
by: Sufang Lin, et al.
Published: (2025-12-01) -
Immunogenicity of coronavirus disease 2019 vaccines in children: A review with ChatGPT
by: Daniel Leung, et al.
Published: (2023-06-01)